Recruiting
Atypical mycobacterial infection
RecruitingStudy on Amikacin for Treating Mycobacterium Xenopi Lung Infection in Patients Using Amikacin and Drug Combination
Registered drugNo placebo
Study on Amikacin for Treating Mycobacterium Xenopi Lung Infection in Patients Using Amikacin and Drug Combination
Registered drugNo placebo
- Disease:Atypical mycobacterial infection
- Substances:AmikacinAmoxicillin+2
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Amikacin
- Sponsor:Centre Hospitalier Universitaire Amiens Picardie